Share on StockTwits

Cardinal Health (NYSE:CAH) EVP Mark R. Blake sold 4,703 shares of the stock on the open market in a transaction that occurred on Monday, May 19th. The stock was sold at an average price of $66.50, for a total value of $312,749.50. Following the transaction, the executive vice president now directly owns 24,416 shares in the company, valued at approximately $1,623,664. The transaction was disclosed in a document filed with the SEC, which is available at this link.

Cardinal Health (NYSE:CAH) traded down 0.53% during mid-day trading on Tuesday, hitting $66.20. The stock had a trading volume of 1,660,703 shares. Cardinal Health has a 1-year low of $45.59 and a 1-year high of $74.40. The stock has a 50-day moving average of $67.19 and a 200-day moving average of $67.46. The company has a market cap of $22.521 billion and a P/E ratio of 66.55.

Cardinal Health (NYSE:CAH) last issued its quarterly earnings data on Thursday, May 1st. The company reported $1.01 EPS for the quarter, meeting the Thomson Reuters consensus estimate of $1.01. The company had revenue of $21.40 million for the quarter, compared to the consensus estimate of $21.72 million. During the same quarter in the prior year, the company posted $1.02 earnings per share. The company’s quarterly revenue was down 12.7% on a year-over-year basis. On average, analysts predict that Cardinal Health will post $3.81 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, July 15th. Investors of record on Tuesday, July 1st will be paid a dividend of $0.3425 per share. This represents a $1.37 annualized dividend and a dividend yield of 2.07%. The ex-dividend date is Friday, June 27th. This is an increase from Cardinal Health’s previous quarterly dividend of $0.30.

A number of analysts have recently weighed in on CAH shares. Analysts at Credit Suisse cut their price target on shares of Cardinal Health from $80.00 to $76.00 in a research note on Monday, May 5th. They now have an “outperform” rating on the stock. Separately, analysts at Barclays reiterated an “overweight” rating on shares of Cardinal Health in a research note on Friday, May 2nd. They now have a $77.00 price target on the stock. Finally, analysts at Mizuho cut their price target on shares of Cardinal Health from $79.00 to $77.00 in a research note on Friday, May 2nd. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the company. Cardinal Health has a consensus rating of “Buy” and a consensus target price of $75.97.

Cardinal Health, Inc is a healthcare services company providing pharmaceutical and medical products and services to pharmacies, hospitals, ambulatory surgery centers, clinical laboratories, physician offices and other healthcare providers.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.